Molecular mechanism of sulphonylurea block of K(ATP) channels carrying mutations that impair ATP inhibition and cause neonatal diabetes.
Sulphonylurea drugs are the therapy of choice for treating neonatal diabetes (ND) caused by mutations in the ATP-sensitive K(+) channel (KATP channel). We investigated the interactions between MgATP, MgADP, and the sulphonylurea gliclazide with KATP channels expressed in Xenopus oocytes. In the abse...
Hoofdauteurs: | Proks, P, De Wet, H, Ashcroft, F |
---|---|
Formaat: | Journal article |
Taal: | English |
Gepubliceerd in: |
2013
|
Gelijkaardige items
-
Phentolamine block of ATP-sensitive K+ channels does not involve interaction with the sulphonylurea receptor, SUR1.
door: Proks, P, et al.
Gepubliceerd in: (1997) -
Interaction of MgATP with the sulphonylurea subunit activates ATP sensitive K-channels receptor
door: Gribble, F, et al.
Gepubliceerd in: (1998) -
How ATP inhibits the open K(ATP) channel.
door: Craig, T, et al.
Gepubliceerd in: (2008) -
Analysis of the differential modulation of sulphonylurea block of beta-cell and cardiac ATP-sensitive K+ (K(ATP)) channels by Mg-nucleotides.
door: Reimann, F, et al.
Gepubliceerd in: (2003) -
Mechanism of K-ATP channel inhibition by ATP
door: Ashcroft, F, et al.
Gepubliceerd in: (1998)